Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a new page release in the system. The change does not alter the visible content or study data on the page.
    Difference
    0.1%
    Check dated 2026-05-17T09:41:33.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a minor update to the site itself rather than a change to the clinical trial study content.
    Difference
    0.1%
    Check dated 2026-04-25T18:54:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T14:36:13.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:25:16.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:50:02.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    The page now displays a new revision label: Revision: v3.4.2. This is a minor meta-update and does not alter study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-02-12T02:22:00.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.